Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Intramuscular Adrenaline on Histamine-Induced Hypotension: A Randomised Placebo-Controlled Pilot Trial.

Allergy·2026
Same author

Ecarin-based coagulation monitoring of argatroban in patients with heparin-induced thrombocytopenia: a prospective observational study.

British journal of anaesthesia·2025
Same author

Mid-Regional Pro-Adrenomedullin Is Associated with Adverse Cardiovascular Outcomes After Cardiac Surgery.

Journal of personalized medicine·2025
Same author

Kinetic Modeling for BT200 to Predict the Level of Plasma-Derived Coagulation Factor VIII in Humans.

The AAPS journal·2024
Same author

Thromboelastography in acute immunologic reactions: a prospective pilot study.

Research and practice in thrombosis and haemostasis·2024
Same author

Bundle branch blocks and cardiovascular mortality in chronic coronary syndrome.

Heart rhythm·2024

Related Experiment Video

Updated: Jun 26, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Platelet dysfunction in outpatients with left ventricular assist devices.

Barbara Steinlechner1, Martin Dworschak, Beatrice Birkenberg

  • 1Division of Cardiothoracic and Vascular Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria. barbara.steinlechner@meduniwien.ac.at

The Annals of Thoracic Surgery
|December 23, 2008
PubMed
Summary

Patients with left ventricular assist devices show impaired platelet function, particularly under high shear rates. This dysfunction, resembling acquired von Willebrand syndrome, contributes to bleeding risks.

More Related Videos

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Related Experiment Videos

Last Updated: Jun 26, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Area of Science:

  • Cardiology
  • Hematology
  • Biomedical Engineering

Background:

  • Left ventricular assist devices (LVADs) are crucial for heart failure management but pose risks of bleeding and clotting.
  • Balancing anticoagulation and procoagulation is vital for LVAD patients.
  • Current coagulation tests overlook platelet function, a critical factor in LVAD complications.

Purpose of the Study:

  • To differentially evaluate platelet function in LVAD outpatients using four point-of-care devices.
  • To identify specific platelet function defects in LVAD patients.

Main Methods:

  • Cross-sectional study comparing 12 LVAD outpatients and 12 healthy volunteers.
  • Assessment of platelet function using thrombelastography platelet mapping, thromboelastometry, platelet function analyzer, and Multiplate whole blood aggregometer.
  • Evaluation of platelet response to collagen, adenosine diphosphate, and ristocetin.

Main Results:

  • LVAD patients exhibited significantly prolonged clotting times and compromised platelet function under high shear stress (collagen/ADP).
  • Despite elevated von Willebrand factor antigen, ristocetin-induced aggregation was reduced, indicating impaired glycoprotein Ib-von Willebrand factor axis function.
  • Abnormal von Willebrand factor multimer patterns were observed in LVAD patients.

Conclusions:

  • Multimodal monitoring reveals significant platelet dysfunction in LVAD patients.
  • Impaired platelet function under high shear and abnormal ristocetin aggregation are partly due to reduced von Willebrand factor activity.
  • These findings suggest an acquired von Willebrand syndrome in LVAD patients, potentially explaining bleeding complications.